Last reviewed · How we verify
NCT06566157: PROMOTE
PROMOTE: The Effect of a Six Week Prebiotic Supplementation on Wellbeing of Young Adults.
NA trial testing Prebiotic in Wellbeing in 70 participants. Not yet recruiting.
16 September 2025
Quick facts
| Lead sponsor | University of Southampton |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 70 |
| Start date | 6 January 2025 |
| Primary completion | 16 September 2025 |
| Estimated completion | 16 September 2026 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Prebiotic — full drug profile →
- Maltodextrin (Corn)
Conditions studied
- Wellbeing — all drugs for Wellbeing →
- Healthy — all drugs for Healthy →
- Mental Health — all drugs for Mental Health →
Sponsor
University of Southampton
Who can join
Adults 18 to 25, any sex, with Wellbeing or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will investigate whether taking a prebiotic for six weeks helps to reduce morning cortisol levels in healthy young adults with mild to moderate stress compared to a placebo. Individuals should continue with their usual lifestyle during the study. Other factors of wellbeing will also be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06566157
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Prebiotic
Trials testing the same drug.
- NCT06588036 — A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population · EARLY_PHASE1 · not yet recruiting
- NCT06495658 — Impact of Prebiotics in Ulcerative Colitis · NA · recruiting
- NCT06411964 — Galactooligosaccharide and Aging · NA · recruiting
- NCT06113003 — The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease · EARLY_PHASE1 · active not recruiting
- NCT06722443 — Impact of Nutritional Intervention With Probiotics and Prebiotics on Obesity. · NA · enrolling by invitation
Other recruiting trials for Wellbeing
Currently open trials in the same condition.
- NCT07494110 — Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations · NA · recruiting
- NCT07480018 — Berberine Supplementation, Sprint Interval Training, and Immune Function Study · NA · recruiting
- NCT07361159 — Health and Wellness Coaching to Improve Thoracic Transplant Caregiver Self-Efficacy · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06871397 — Effectiveness of an Online Biopsychosocial Intervention to Improve Well-being and Mental Health During Pregnancy · NA · recruiting
Other University of Southampton trials
Trials by the same sponsor.
- NCT07531277 — Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Prim · NA · not yet recruiting
- NCT06923943 — Predicting Nurse Staffing Requirements From Routinely Collected Data · active not recruiting
- NCT06692959 — A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer · Phase 2 · recruiting
- NCT06815120 — A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent · NA · not yet recruiting
- NCT06932224 — This Study Aims to Measure the Effect of Acute Hospitalisation on the Physical and Cognitive Functioning of Older Orthop · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06566157 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southampton
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06566157.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing